Evista

Evista (Raloxifene Hydrochloride) is a medication used to treat and prevent osteoporosis in postmenopausal women. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs).

Evista is primarily used for the prevention and treatment of osteoporosis in postmenopausal women. It works by mimicking the effects of estrogen in some tissues, such as bones, to help maintain bone density and reduce the risk of fractures. Evista is also sometimes used to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis or at high risk for the disease.

Common effects of Evista may include hot flashes, leg cramps, and swelling in the legs. Some users may also experience flu-like symptoms, joint pain, or sweating. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Evista should be used with caution in individuals with a history of blood clots or stroke. It is important to inform your healthcare provider about any medical conditions or allergies before starting Evista. Regular monitoring may be required to ensure the medication is working effectively and to check for any potential side effects.

Evista may interact with certain medications, including cholesterol-lowering drugs and some antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using Evista, as it may increase the risk of side effects.